62 related articles for article (PubMed ID: 21266106)
21. Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells.
Muñoz-Gámez JA; Quiles-Pérez R; Ruiz-Extremera A; Martín-Álvarez AB; Sanjuan-Nuñez L; Carazo A; León J; Oliver FJ; Salmerón J
Cancer Lett; 2011 Feb; 301(1):47-56. PubMed ID: 21093979
[TBL] [Abstract][Full Text] [Related]
22. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
23. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.
Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR
Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574
[TBL] [Abstract][Full Text] [Related]
24. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
[TBL] [Abstract][Full Text] [Related]
25. Doxorubicin induces ZAKα overexpression with a subsequent enhancement of apoptosis and attenuation of survivability in human osteosarcoma cells.
Fu CY; Tseng YS; Chen MC; Hsu HH; Yang JJ; Tu CC; Lin YM; Viswanadha VP; Kuo WW; Huang CY
Environ Toxicol; 2018 Feb; 33(2):191-197. PubMed ID: 29105997
[TBL] [Abstract][Full Text] [Related]
26. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs.
Fromigué O; Hamidouche Z; Marie PJ
J Pharmacol Exp Ther; 2008 May; 325(2):595-600. PubMed ID: 18252811
[TBL] [Abstract][Full Text] [Related]
27. [Selective inducement effect of bacterial redox protein azurin on apoptosis of human osteosarcoma cell line U2OS].
Ye ZM; Miao XD; Yang DS; Xu RZ; Huang X; Ge FF
Ai Zheng; 2005 Mar; 24(3):298-304. PubMed ID: 15757530
[TBL] [Abstract][Full Text] [Related]
28. Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
Cancer Res; 1999 May; 59(9):2190-4. PubMed ID: 10232607
[TBL] [Abstract][Full Text] [Related]
29. Differential apoptotic response in HPV-infected cancer cells of the uterine cervix after doxorubicin treatment.
Suh DS; Kim SC; An WG; Lee CH; Choi KU; Song JM; Jung JS; Lee KS; Yoon MS
Oncol Rep; 2010 Mar; 23(3):751-6. PubMed ID: 20127016
[TBL] [Abstract][Full Text] [Related]
30. N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells.
Kim BM; Choi YJ; Han Y; Yun YS; Hong SH
Toxicol Appl Pharmacol; 2009 Aug; 239(1):87-97. PubMed ID: 19481559
[TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis by Hax-1 siRNA in melanoma cells.
Li WB; Feng J; Geng SM; Zhang PY; Yan XN; Hu G; Zhang CQ; Shi BJ
Cell Biol Int; 2009 Apr; 33(4):548-54. PubMed ID: 19254774
[TBL] [Abstract][Full Text] [Related]
32. Targeting hedgehog-GLI-2 pathway in osteosarcoma.
Yang W; Liu X; Choy E; Mankin H; Hornicek FJ; Duan Z
J Orthop Res; 2013 Mar; 31(3):502-9. PubMed ID: 22968906
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
Bruheim S; Xi Y; Ju J; Fodstad O
Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113
[TBL] [Abstract][Full Text] [Related]
34. Solamargine induces apoptosis associated with p53 transcription-dependent and transcription-independent pathways in human osteosarcoma U2OS cells.
Li X; Zhao Y; Wu WK; Liu S; Cui M; Lou H
Life Sci; 2011 Feb; 88(7-8):314-21. PubMed ID: 21163271
[TBL] [Abstract][Full Text] [Related]
35. Targeted therapy of human osteosarcoma with 17AAG or rapamycin: characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways.
Gazitt Y; Kolaparthi V; Moncada K; Thomas C; Freeman J
Int J Oncol; 2009 Feb; 34(2):551-61. PubMed ID: 19148492
[TBL] [Abstract][Full Text] [Related]
36. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
[TBL] [Abstract][Full Text] [Related]
37. [Interferon α sensitizes human osteosarcoma cells to doxorubicin-induced apoptosis through p53-dependent pathway].
Yuan XW; Huang XF; Chen ZX; Liang SG; Liao WM
Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(37):3008-3013. PubMed ID: 27760664
[No Abstract] [Full Text] [Related]
38. Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?
Hattinger CM; Fanelli M; Tavanti E; Vella S; Riganti C; Picci P; Serra M
Future Oncol; 2017 Apr; 13(8):673-677. PubMed ID: 28183198
[No Abstract] [Full Text] [Related]
39. Voltage-gated potassium channel Kv1.3 is highly expressed in human osteosarcoma and promotes osteosarcoma growth.
Wu J; Zhong D; Wu X; Sha M; Kang L; Ding Z
Int J Mol Sci; 2013 Sep; 14(9):19245-56. PubMed ID: 24065104
[TBL] [Abstract][Full Text] [Related]
40. Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma.
Coutinho L; Oliveira H; Pacheco AR; Almeida L; Pimentel F; Santos C; Ferreira de Oliveira JM
DNA Repair (Amst); 2017 Feb; 50():36-42. PubMed ID: 28063664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
